Urine Proteome Analysis May Allow Noninvasive Differential Diagnosis of Diabetic Nephropathy
Overview
Authors
Affiliations
Objective: Chronic renal insufficiency and/or proteinuria in type 2 diabetes may stem from chronic renal diseases (CKD) other than classic diabetic nephropathy in more than one-third of patients. We interrogated urine proteomic profiles generated by surface-enhanced laser desorption/ionization-time of flight/mass spectrometry with the aim of isolating a set of biomarkers able to reliably identify biopsy-proven diabetic nephropathy and to establish a stringent correlation with the different patterns of renal injury.
Research Design And Methods: Ten micrograms of urine proteins from 190 subjects (20 healthy subjects, 20 normoalbuminuric, and 18 microalbuminuric diabetic patients and 132 patients with biopsy-proven nephropathy: 65 diabetic nephropathy, 10 diabetic with nondiabetic CKD [nd-CKD], and 57 nondiabetic with CKD) were run using a CM10 ProteinChip array and analyzed by supervised learning methods (Classification and Regression Tree analysis).
Results: The classification model correctly identified 75% of patients with normoalbuminuria, 87.5% of those with microalbuminuria, and 87.5% of those with diabetic nephropathy when applied to a blinded testing set. Most importantly, it was able to reliably differentiate diabetic nephropathy from nd-CKD in both diabetic and nondiabetic patients. Among the best predictors of the classification model, we identified and validated two proteins, ubiquitin and β2-microglobulin.
Conclusions: Our data suggest the presence of a specific urine proteomic signature able to reliably identify type 2 diabetic patients with diabetic glomerulosclerosis.
Diagnostic value of α1-MG and URBP in early diabetic renal impairment.
Zhou Y, Zhang Y, Chen J, Wang T, Li H, Wu F Front Physiol. 2023; 14:1173982.
PMID: 37929213 PMC: 10621041. DOI: 10.3389/fphys.2023.1173982.
Insulin and the kidneys: a contemporary view on the molecular basis.
Daza-Arnedo R, Rico-Fontalvo J, Aroca-Martinez G, Rodriguez-Yanez T, Martinez-Avila M, Almanza-Hurtado A Front Nephrol. 2023; 3:1133352.
PMID: 37675359 PMC: 10479562. DOI: 10.3389/fneph.2023.1133352.
Phillips J, Chen J, Ooi E, Prunster J, Lim W Front Clin Diabetes Healthc. 2023; 2:731574.
PMID: 36994340 PMC: 10012134. DOI: 10.3389/fcdhc.2021.731574.
Effects of Smoking on Diabetic Nephropathy.
Gundogdu Y, Anaforoglu I Front Clin Diabetes Healthc. 2023; 3:826383.
PMID: 36992741 PMC: 10012135. DOI: 10.3389/fcdhc.2022.826383.
Early renal structural changes and potential biomarkers in diabetic nephropathy.
Liu H, Feng J, Tang L Front Physiol. 2022; 13:1020443.
PMID: 36425298 PMC: 9679365. DOI: 10.3389/fphys.2022.1020443.